Internal Medicine, Rheumatology · Hickory, NC
NPI
1639121239
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
225 18th St SE
Hickory, NC, 28602
Phone (828) 322-9912
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
145,666 services
Medicare patients, 2024
339
Average age 73
Drug cost, 2024
$5.2M
9,389 prescriptions
Company payments, 2025
$1,386
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dayton D Payne Jr. was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 95,600 times for 29 patients. In total Dayton D Payne Jr. billed 145,666 services in 33 codes, and Medicare paid $1.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 95,600 | 29 | $3.60 | $344K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 12,650 | 15 | $33.81 | $428K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 12,550 | 16 | $9.05 | $114K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 4,510 | 13 | $23.04 | $104K |
| J0897 Injection, denosumab, 1 mg | Office | 2,100 | 21 | $20.51 | $43K |
| 96372 Injection Administration | Office | 517 | 54 | $10.72 | $5,544 |
| 99214 Office E&M - Established | Office | 448 | 219 | $82.69 | $37K |
| 96413 Chemotherapy Administration | Office | 264 | 47 | $94.62 | $25K |
| 96415 Chemotherapy Administration | Office | 211 | 28 | $20.44 | $4,314 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 198 | 27 | $0.74 | $146 |
| 96365 Intravenous Infusion, Hydration | Office | 162 | 15 | $45.96 | $7,446 |
| 99213 Office E&M - Established | Office | 154 | 97 | $62.70 | $9,655 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 148 | 18 | $0.24 | $35.24 |
| 99204 Office E&M - New | Office | 39 | 39 | $122.12 | $4,763 |
| 20610 Joint Injection | Office | 35 | 22 | $50.93 | $1,783 |
By year: 2022 $1.8M for 143,148 services; 2023 $1.4M for 148,541 services; 2024 $1.4M for 145,666 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dayton D Payne Jr. prescribed most often to Medicare patients was Prednisone, with 1,073 prescriptions and refills. In total Dayton D Payne Jr. wrote 9,389 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,073 | 1,472 | 232 | $6,668 |
| Tramadol Hcl Generic | 665 | 701 | 106 | $6,866 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 621 | 629 | 75 | $19K |
| Methotrexate Methotrexate Sodium | 526 | 955 | 110 | $8,579 |
| Hydroxychloroquine Sulfate Generic | 463 | 762 | 104 | $15K |
| Diclofenac Sodium Generic | 393 | 494 | 81 | $9,377 |
| Celecoxib Generic | 330 | 469 | 71 | $11K |
| Gabapentin Generic | 288 | 418 | 53 | $4,024 |
| Pregabalin Generic | 234 | 276 | 36 | $3,979 |
| Cyclobenzaprine Hcl Generic | 220 | 281 | 39 | $1,637 |
| Duloxetine Hcl Generic | 204 | 345 | 46 | $2,974 |
| Leflunomide Generic | 199 | 349 | 47 | $10K |
| Oxycodone Hcl Generic | 189 | 189 | 15 | $3,689 |
| Nabumetone Generic | 175 | 224 | 51 | $1,491 |
| Zolpidem Tartrate Generic | 136 | 154 | 16 | $552 |
Brand drugs: - claims; generic drugs: 8,559 claims; opioid claims: 1,803.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dayton D Payne Jr. $1,386 ($1,386 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $256.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 20 | $256 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $180 |
| UCB, Inc. UCB.BR | 12 | $179 |
| Abbvie Inc. ABBV | 15 | $177 |
| Janssen Biotech, Inc. JNJ | 10 | $150 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $87.31 |
| Pfizer Inc. PFE | 4 | $83.97 |
| Radius Health, Inc. | 3 | $66.04 |
| GlaxoSmithKline, LLC. GSK | 3 | $65.95 |
| Sandoz Inc. SDZ.SW | 2 | $30.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.